Banco Bilbao Vizcaya Argentaria SA vs Illumina, Inc. — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $28.6 (market cap $157.51B), while Illumina, Inc. trades at $193.06 (market cap $28.96B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 5.4× Illumina, Inc.'s market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 3.8% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| BBVA | ILMN | |
|---|---|---|
Market Cap | $157.51B | $28.96B |
Sector | Financials | Health |
52-Week High | $28.50 | $205.10 |
52-Week Low | $17.96 | $91.00 |
Dividend Yield | 3.8% | — |
Enterprise Value | — | $30.32B |
Trailing returns across standard periods
Latest headlines on both assets
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →